Advent Capital Management /De/

Holdings History for INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0

Investment type: Debt / NOTE 3.250% 7/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
12/31/2021		0%	$0	0	-4,000	-100%		Q4 2021
9/30/2021	0%	+0%	$4K	4K	+4,000	NEW	$1.00	Q3 2021
6/30/2021		-0.49%	$0	0	-27,701,000	-100%		Q2 2021
3/31/2021	0.49%	+0.01%	$22.8M	27.7M	+304,000	+1.11%	$0.82	Q1 2021
12/31/2020	0.46%	-0.03%	$21.7M	27.4M	-1,581,000	-5.46%	$0.79	Q4 2020
9/30/2020	0.52%	0%	$23.5M	29M	-66,000	-0.23%	$0.81	Q3 2020
6/30/2020	0.51%	-0.12%	$21.5M	29M	-7,067,000	-19.6%	$0.74	Q2 2020
3/31/2020	0.64%	-0.15%	$29.4M	36.1M	-8,514,000	-19.1%	$0.82	Q1 2020
12/31/2019	0.88%	-0.02%	$45.3M	44.6M	-1,115,000	-2.44%	$1.01	Q4 2019
9/30/2019	0.74%	-0.09%	$39.3M	45.7M	-5,505,000	-10.7%	$0.86	Q3 2019
6/30/2019	0.89%	-0.01%	$45.7M	51.2M	-502,000	-0.97%	$0.89	Q2 2019
3/31/2019	1.13%	+0.63%	$51.3M	51.7M	+28,629,000	+124%	$0.99	Q1 2019
12/31/2018	0.52%	-0.13%	$21.3M	23.1M	-5,745,000	-19.9%	$0.92	Q4 2018
9/30/2018	0.61%	+0.08%	$29.2M	28.9M	+3,763,000	+15%	$1.01	Q3 2018
6/30/2018	0.47%	+0.07%	$21.9M	25.1M	+3,587,000	+16.7%	$0.87	Q2 2018
3/31/2018	0.34%	-0.05%	$17.2M	21.5M	-2,902,000	-11.9%	$0.80	Q1 2018
12/31/2017	0.37%	-0.01%	$19.5M	24.4M	-351,000	-1.42%	$0.80	Q4 2017
9/30/2017	0.37%	+0.25%	$19.3M	24.8M	+17,078,000	+222%	$0.78	Q3 2017
6/30/2017	0.14%	0%	$7.47M	7.69M	-135,000	-1.73%	$0.97	Q2 2017
3/31/2017	0.14%	-0.03%	$7.3M	7.82M	-1,456,000	-15.7%	$0.93	Q1 2017
12/31/2016	0.15%	0%	$8.33M	9.28M	-2,000	-0.02%	$0.90	Q4 2016
9/30/2016	0.15%	-0.01%	$10.4M	9.28M	-719,000	-7.19%	$1.12	Q3 2016
6/30/2016	0.16%	+0.16%	$10.3M	10M	+10,000,000	NEW	$1.03	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.